Drugs / combined diphtheria and tetanus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01267058 Comparator | Sep 1997 → Feb 1998 | diphtheria, pertussis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | combined diphtheria and tetanus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01267058 ↗ |
| Modality | Vaccine | “Commonwealth Serum Laboratories' combined diphtheria and tetanus vaccine” NCT01267058 ↗ |
| Route | Intramuscular | “Intramuscular, single dose” NCT01267058 ↗ |